Cargando…
MiR-520b as a novel molecular target for suppressing stemness phenotype of head-neck cancer by inhibiting CD44
Cancer stem cells preferentially acquire the specific characteristics of stress tolerance and high mobility, allowing them to progress to a therapy-refractive state. To identify a critical molecule to regulate cancer stemness is indispensable to erratically cure cancer. In this study, we identified...
Autores principales: | Lu, Ya-Ching, Cheng, Ann-Joy, Lee, Li-Yu, You, Guo-Rung, Li, Yan-Liang, Chen, Hsin-Ying, Chang, Joseph T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435724/ https://www.ncbi.nlm.nih.gov/pubmed/28515423 http://dx.doi.org/10.1038/s41598-017-02058-8 |
Ejemplares similares
-
CD44s and CD44v6 Expression in Head and Neck Epithelia
por: Mack, Brigitte, et al.
Publicado: (2008) -
Hsa-miR-520d Converts Fibroblasts into CD105+ Populations
por: Ishihara, Yoshitaka, et al.
Publicado: (2014) -
Systemic Investigation Identifying Salivary miR-196b as a Promising Biomarker for Early Detection of Head-Neck Cancer and Oral Precancer Lesions
por: Cheng, Ann-Joy, et al.
Publicado: (2021) -
CD44s Induces miR-629-3p Expression in Association with Cisplatin Resistance in Head and Neck Cancer Cells
por: Chikuda, Junichiro, et al.
Publicado: (2020) -
LncRNA ZFAS1 contributes to osteosarcoma progression via miR-520b and miR-520e-mediated inhibition of RHOC signaling
por: Liu, Xiaofeng, et al.
Publicado: (2022)